Are the Recommended Criteria for Clinically Insignificant Prostate Cancer Applicable to 12-core Prostate Biopsy Scheme? A Multicentre Study of Urooncology Association, Turkey

Celik, Serdar; KIZILAY, FUAT; YÖRÜKOĞLU, KUTSAL; Ozen, Haluk; AKDOĞAN, BÜLENT; İZOL, VOLKAN; BAYAZIT, YILDIRIM; ASLAN, GÜVEN; Sozen, Sinan; BALTACI, Sümer; MÜEZZİNOĞLU, TALHA; Narter, Fehmi; TURKERI, LEVENT

doi:10.4274/uob.galenos.2020.1677

Are the Recommended Criteria for Clinically Insignificant Prostate Cancer Applicable to 12-core Prostate Biopsy Scheme? A Multicentre Study of Urooncology Association, Turkey

Copy For Citation

Celik S., KIZILAY F., YÖRÜKOĞLU K., Ozen H., AKDOĞAN B., İZOL V., ...More

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, vol.20, no.1, pp.19-25, 2021 (ESCI)

Publication Type: Article / Article
Volume: 20 Issue: 1
Publication Date: 2021
Doi Number: 10.4274/uob.galenos.2020.1677
Journal Name: UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY
Journal Indexes: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
Page Numbers: pp.19-25
Hacettepe University Affiliated: Yes

Abstract

Objective: The aim of this study is to investigate the relevance of the Epstein criteria for the 12-core transrectal prostate biopsy (TRUS-Bx) scheme with the evaluation of clinicopathologic data recorded in the Urologic Cancer Database - Prostate (UroCaD-P), Urooncology Association, Turkey (UOAT).